Real-time enrollment status for this relapsed or refractory multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT05652335 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT05652335 is currently recruiting participants. This clinical trial study for relapsed or refractory multiple myeloma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05652335 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05652335 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.